ATE493511T1 - Oligonukleotide zur brustkrebsdiagnose - Google Patents

Oligonukleotide zur brustkrebsdiagnose

Info

Publication number
ATE493511T1
ATE493511T1 AT05747218T AT05747218T ATE493511T1 AT E493511 T1 ATE493511 T1 AT E493511T1 AT 05747218 T AT05747218 T AT 05747218T AT 05747218 T AT05747218 T AT 05747218T AT E493511 T1 ATE493511 T1 AT E493511T1
Authority
AT
Austria
Prior art keywords
oligonucleotides
breast cancer
cancer diagnostics
diagnostics
breast
Prior art date
Application number
AT05747218T
Other languages
English (en)
Inventor
Praveen Sharma
Anders Loenneborg
Original Assignee
Diagenic As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagenic As filed Critical Diagenic As
Application granted granted Critical
Publication of ATE493511T1 publication Critical patent/ATE493511T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT05747218T 2004-06-02 2005-06-02 Oligonukleotide zur brustkrebsdiagnose ATE493511T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0412301.4A GB0412301D0 (en) 2004-06-02 2004-06-02 Product and method
PCT/GB2005/002180 WO2005118851A1 (en) 2004-06-02 2005-06-02 Oligonucleotides for cancer diagnosis

Publications (1)

Publication Number Publication Date
ATE493511T1 true ATE493511T1 (de) 2011-01-15

Family

ID=32696533

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05747218T ATE493511T1 (de) 2004-06-02 2005-06-02 Oligonukleotide zur brustkrebsdiagnose

Country Status (17)

Country Link
US (2) US8105773B2 (de)
EP (1) EP1766056B1 (de)
JP (1) JP5060945B2 (de)
CN (1) CN101027410A (de)
AP (1) AP2006003862A0 (de)
AT (1) ATE493511T1 (de)
AU (1) AU2005250219B2 (de)
CA (1) CA2568889A1 (de)
DE (1) DE602005025633D1 (de)
DK (1) DK1766056T3 (de)
ES (1) ES2358910T3 (de)
GB (1) GB0412301D0 (de)
NO (1) NO20065939L (de)
NZ (1) NZ551797A (de)
SI (1) SI1766056T1 (de)
WO (1) WO2005118851A1 (de)
ZA (1) ZA200610644B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006128082A2 (en) * 2005-05-26 2006-11-30 The Johns Hopkins University Biomarkers for breast cancer
JP2007275027A (ja) * 2006-04-12 2007-10-25 Fujifilm Corp 癌関連欠失遺伝子マーカーを用いた癌の診断方法
JP5208477B2 (ja) * 2007-10-12 2013-06-12 生化学工業株式会社 遺伝子サブトラクション用の担体及びその利用
WO2011063232A1 (en) * 2009-11-20 2011-05-26 University Of Louisville Research Foundation, Inc. Biomarkers of cancer
GB201000688D0 (en) * 2010-01-15 2010-03-03 Diagenic Asa Product and method
CN110444287B (zh) * 2011-04-29 2024-02-06 癌症预防和治疗有限公司 使用分类系统及其试剂盒识别和诊断肺部疾病的方法
KR20140099874A (ko) * 2011-11-02 2014-08-13 나노프리시젼 프로덕츠 인코포레이션 캐스텔레이티드 광섬유 케이블 유지 구조
JP6486826B2 (ja) 2012-10-01 2019-03-20 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 阻害剤に対する応答を予測するためのバイオマーカーおよび方法、ならびにそれらの使用
EP2922971B1 (de) * 2012-11-20 2018-10-17 Lund, Tore Eiliv Genexpressionsprofil in einer diagnostik
JP6498210B2 (ja) 2013-12-29 2019-04-10 チュアラボ オンコロジー, インコーポレーテッドCurelab Oncology, Inc. 炎症関連疾患の治療と予防のためのｐ６２／ｓｑｓｔｍ１に関する方法と組成物
KR102523245B1 (ko) * 2014-06-18 2023-04-20 도레이 카부시키가이샤 식도암의 검출 키트 또는 디바이스 및 검출 방법
FR3029210A1 (fr) 2014-11-27 2016-06-03 Centre Nat De La Rech Scient (Cnrs) Methode de pronostic d'hemopathies
US10140708B2 (en) * 2016-01-21 2018-11-27 Riverside Research Institute Method for gestational age estimation and embryonic mutant detection
GB201611738D0 (en) * 2016-07-05 2016-08-17 Cambridge Entpr Ltd Biomarkers for inflammatory bowel disease
WO2019036388A1 (en) * 2017-08-14 2019-02-21 Raytheon Company ALGORITHM OF SUBTRACTION FOR DETECTION OF TUMORS
CN109529018B (zh) * 2019-01-10 2021-11-30 南方医科大学南方医院 Atxn2l用于制备逆转胃癌奥沙利铂耐药的药物的用途
CN109596611A (zh) * 2019-01-21 2019-04-09 湖北紫荆生物技术有限公司 一种水体钙含量测试剂及水体钙含量测量方法
US11475558B2 (en) 2019-11-13 2022-10-18 Raytheon Company Organ isolation in scan data
US11282209B2 (en) 2020-01-10 2022-03-22 Raytheon Company System and method for generating contours
US11562512B2 (en) 2020-12-09 2023-01-24 Raytheon Company System and method for generating and displaying contours
US11893745B2 (en) 2020-12-09 2024-02-06 Raytheon Company System and method for generating and displaying contours
CN113913436B (zh) * 2021-11-18 2023-09-29 天津市肿瘤医院（天津医科大学肿瘤医院） 逆转录转座基因l1-atp8b1及其作为肺鳞癌标志物的用途和治疗肺鳞癌的药物
CN115976212B (zh) * 2022-12-21 2024-06-11 四川大学华西医院 一种用于检测骨肿瘤诊断相关基因的探针库及试剂盒

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981783A (en) 1986-04-16 1991-01-01 Montefiore Medical Center Method for detecting pathological conditions
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5871928A (en) 1989-06-07 1999-02-16 Fodor; Stephen P. A. Methods for nucleic acid analysis
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5925525A (en) 1989-06-07 1999-07-20 Affymetrix, Inc. Method of identifying nucleotide differences
JP2802125B2 (ja) 1989-06-23 1998-09-24 キヤノン株式会社 核酸の検出方法
US5474796A (en) 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
DE69214243T2 (de) 1991-09-23 1997-02-06 Pfizer Verfahren für die Detektion von spezifische mRNS und DNS in Zellen
GB2260811B (en) 1991-10-23 1995-07-05 Yorkshire Cancer Research Camp Detection of malignant tumours
AU691469B2 (en) 1992-03-04 1998-05-21 Synaptic Pharmaceutical Corporation DNA encoding taurine and gaba transporters and uses thereof
US6114114A (en) 1992-07-17 2000-09-05 Incyte Pharmaceuticals, Inc. Comparative gene transcript analysis
US5633137A (en) 1992-12-01 1997-05-27 The University Of South Florida Method for measuring specific gene expression: transcriptional activity per gene dose
US5677125A (en) 1994-01-14 1997-10-14 Vanderbilt University Method of detection and diagnosis of pre-invasive cancer
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5545531A (en) 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US6156502A (en) 1995-12-21 2000-12-05 Beattie; Kenneth Loren Arbitrary sequence oligonucleotide fingerprinting
AU2253397A (en) 1996-01-23 1997-08-20 Affymetrix, Inc. Nucleic acid analysis techniques
WO1997029212A1 (en) 1996-02-08 1997-08-14 Affymetrix, Inc. Chip-based speciation and phenotypic characterization of microorganisms
WO1998008083A1 (en) 1996-08-20 1998-02-26 Motorola Inc. Method and apparatus for detecting predetermined molecular structures in a sample
US6235474B1 (en) 1996-12-30 2001-05-22 The Johns Hopkins University Methods and kits for diagnosing and determination of the predisposition for diseases
US6190857B1 (en) 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
NO972006D0 (no) * 1997-04-30 1997-04-30 Forskningsparken I Aas As Ny metode for diagnose av sykdommer
US5994076A (en) 1997-05-21 1999-11-30 Clontech Laboratories, Inc. Methods of assaying differential expression
WO1999006831A2 (en) 1997-07-29 1999-02-11 Dorssers Lambert C J Breast cancer resistance genes, methods for their detection and uses thereof
US6607879B1 (en) 1998-02-09 2003-08-19 Incyte Corporation Compositions for the detection of blood cell and immunological response gene expression
US6174680B1 (en) * 1998-12-30 2001-01-16 Dana-Farber Cancer Institute, Inc. Method for identifying mismatch repair glycosylase reactive sites, compounds and uses thereof
CA2318789C (en) 1998-02-25 2011-05-10 The United States Of America As Represented By The Secretary Department Of Health And Human Services Cellular arrays for rapid molecular profiling
US6004755A (en) 1998-04-07 1999-12-21 Incyte Pharmaceuticals, Inc. Quantitative microarray hybridizaton assays
CN1313908A (zh) 1998-08-21 2001-09-19 纳克斯科尔公司 使用可交联的固定的核酸的检测法
US20090233276A1 (en) * 1998-09-22 2009-09-17 Oncomedx, Inc. Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions
US6593084B2 (en) 1998-10-13 2003-07-15 Robert E. Bird Carcinogen assay
WO2000022172A1 (en) 1998-10-13 2000-04-20 Clontech Laboratories, Inc. Nucleic acid arrays
JP5213202B2 (ja) 1998-10-28 2013-06-19 バイシス・インコーポレーテツド 細胞アレイならびに遺伝障害マーカーの検出および使用方法
WO2000026412A1 (en) 1998-11-02 2000-05-11 Kenneth Loren Beattie Nucleic acid analysis using sequence-targeted tandem hybridization
US20040241726A1 (en) 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of allergies related gene transcripts in blood
US20050042630A1 (en) 1999-01-06 2005-02-24 Chondrogene Limited Method for the detection of asthma related gene transcripts in blood
US20040248169A1 (en) 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of obesity related gene transcripts in blood
US20040265868A1 (en) 1999-01-06 2004-12-30 Chondrogene Limited Method for the detection of depression related gene transcripts in blood
US20050123938A1 (en) 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
WO2000040749A2 (en) 1999-01-06 2000-07-13 Genenews Inc. Method for the detection of gene transcripts in blood and uses thereof
US20040241728A1 (en) 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of lung disease related gene transcripts in blood
US20040265869A1 (en) 1999-01-06 2004-12-30 Chondrogene Limited Method for the detection of type II diabetes related gene transcripts in blood
US20050003394A1 (en) 1999-01-06 2005-01-06 Chondrogene Limited Method for the detection of rheumatoid arthritis related gene transcripts in blood
US20040248170A1 (en) 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of hyperlipidemia related gene transcripts in blood
US7473528B2 (en) 1999-01-06 2009-01-06 Genenews Inc. Method for the detection of Chagas disease related gene transcripts in blood
US20040241727A1 (en) 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of schizophrenia related gene transcripts in blood
DE19937187A1 (de) * 1999-08-06 2001-03-01 Qiagen Gmbh Automatisierte Proteinreinigung im Multiwellformat durch Vakuumfiltration
AU2001278076A1 (en) * 2000-07-26 2002-02-05 Applied Genomics, Inc. Bstp-5 proteins and related reagents and methods of use thereof
US7108969B1 (en) * 2000-09-08 2006-09-19 Affymetrix, Inc. Methods for detecting and diagnosing oral cancer
US6955876B2 (en) * 2000-11-01 2005-10-18 Kane Michael D Compositions and systems for identifying and comparing expressed genes (mRNAs) in eukaryotic organisms
WO2002059367A2 (en) 2000-11-30 2002-08-01 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Diagnostic microarray for inflammatory bowel disease, crohn's disease and ulcerative colitis
EP1350114A2 (de) * 2001-01-12 2003-10-08 Yale University Nachweis von survivin in biologischen flüssigkeiten von krebspatienten
US20020132274A1 (en) * 2001-01-17 2002-09-19 Nevalainen Marja T. Diagnostic and monitorings methods for cancer
AU2002253878A1 (en) 2001-01-25 2002-08-06 Gene Logic, Inc. Gene expression profiles in breast tissue
AU2002237124B2 (en) 2001-02-28 2008-03-06 Chondrogene Inc. Compositions and methods relating to osteoarthritis
WO2002088750A2 (en) * 2001-05-02 2002-11-07 Oxford Glycosciences (Uk) Ltd Proteins, genes and their use for diagnosis and treatment of breast cancer
US20020169560A1 (en) 2001-05-12 2002-11-14 X-Mine Analysis mechanism for genetic data
US7335467B2 (en) * 2001-05-15 2008-02-26 Ludwig Institute For Cancer Research Breast cancer antigens
US20030036077A1 (en) * 2001-05-31 2003-02-20 Chronix Biomedical Methods for generating an mRNA expression profile from an ecellular mRNA containing blood sample and using the same to identify functional state markers
WO2003001985A2 (en) * 2001-06-28 2003-01-09 Dermtech International Method for detection of melanoma
WO2003008963A1 (en) * 2001-07-18 2003-01-30 University Of Louisville Research Foundation, Inc. E-genechip online web service for data mining bioinformatics
US7229774B2 (en) * 2001-08-02 2007-06-12 Regents Of The University Of Michigan Expression profile of prostate cancer
US7622260B2 (en) * 2001-09-05 2009-11-24 The Brigham And Women's Hospital, Inc. Diagnostic and prognostic tests
US7371736B2 (en) * 2001-11-07 2008-05-13 The Board Of Trustees Of The University Of Arkansas Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss
US7668659B2 (en) * 2001-11-07 2010-02-23 The Board Of Trustees Of The University Of Arkansas Diagnosis and classification of multiple myeloma
US20030232350A1 (en) * 2001-11-13 2003-12-18 Eos Biotechnology, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
WO2003041562A2 (en) * 2001-11-14 2003-05-22 Whitehead Institute For Biomedical Research Molecular cancer diagnosis using tumor gene expression signature
AU2002361908A1 (en) * 2001-12-31 2003-07-24 Quark Biotech, Inc. Methods for identifying marker genes for cancer
US20030195431A1 (en) * 2002-04-10 2003-10-16 Sukhatme Vikas P. Observation of effects of body fluids on indicator cells for disease diagnosis
WO2003100000A2 (en) * 2002-05-24 2003-12-04 Tularik Inc. Amplification and overexpression of oncogenes
CN100478689C (zh) * 2002-08-30 2009-04-15 肿瘤疗法科学股份有限公司 多肽及其用途
EP1581652A4 (de) 2002-09-12 2008-02-13 Genenews Corp Identifizerung von insbesondere zur diagnose und identifizierung therapeutischer ziele für osteoarthritis geeigneten sequenzen
US20060024692A1 (en) * 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
GB0227238D0 (en) * 2002-11-21 2002-12-31 Diagenic As Product and method
US7910550B2 (en) * 2004-04-16 2011-03-22 Stc.Unm Human kunitz-type inhibitor with enhanced antifibrinolytic activity
EP1809765A2 (de) * 2004-11-04 2007-07-25 Roche Diagnostics GmbH Klassifizierung von aml (akuter myeloider leukämie)
US20070178503A1 (en) * 2005-12-19 2007-08-02 Feng Jiang In-situ genomic DNA chip for detection of cancer

Also Published As

Publication number Publication date
NZ551797A (en) 2010-03-26
JP2008501332A (ja) 2008-01-24
AU2005250219A1 (en) 2005-12-15
US20120295800A1 (en) 2012-11-22
AU2005250219B2 (en) 2011-01-20
ZA200610644B (en) 2008-07-30
SI1766056T1 (sl) 2011-05-31
EP1766056B1 (de) 2010-12-29
CA2568889A1 (en) 2005-12-15
US8105773B2 (en) 2012-01-31
DE602005025633D1 (de) 2011-02-10
JP5060945B2 (ja) 2012-10-31
DK1766056T3 (da) 2011-03-14
GB0412301D0 (en) 2004-07-07
US20080026385A1 (en) 2008-01-31
WO2005118851A1 (en) 2005-12-15
CN101027410A (zh) 2007-08-29
AP2006003862A0 (en) 2006-12-31
EP1766056A1 (de) 2007-03-28
ES2358910T3 (es) 2011-05-16
NO20065939L (no) 2007-02-08

Similar Documents

Publication Publication Date Title
ATE493511T1 (de) Oligonukleotide zur brustkrebsdiagnose
PL1720611T3 (pl) Marker diagnostyczny dla raka
BRPI0810206A2 (pt) Método de tratar câncer
DE602005010597D1 (de) Bildaufzeichnungsverfahren
IL197914A (en) Antibodies to ereg for cancer treatment
DK1954834T3 (da) Brystcancermarkører
EP1996700A4 (de) Krebserkrankungen modifizierender antikörper 141205-05
EP1802764A4 (de) Biomarker für brustkrebs
DK1907574T3 (da) Oligonukleotider
EP1996699A4 (de) Antikörper, die krebserkrankungen modifizieren
EP1907857A4 (de) Biomarker für brustkrebs
EP1862804A4 (de) Verfahren zur diagnose von prostatakrebs
FI20055534A0 (fi) Menetelmä verkkosuolen valmistamiseksi
BRPI0807858A2 (pt) Anticorpo de modificação de doença cancerosa
EP1946118A4 (de) Gewebediagnose für brustkrebs
HK1108924A1 (en) Cancer prognostic methods
EP2044119A4 (de) Antikörper, die krebserkrankungen modifizieren
EP2029172A4 (de) Antikörper gegen c35 zur behandlung von krebs
EP1915456A4 (de) Antikörper, die krebserkrankungen modifizieren
ITMI20051107A1 (it) Metodo per il trattamento del cancro
BRPI0807861A2 (pt) Anticorpo de modificação de doença cancerosa
EP2106441A4 (de) Antikörper zur modifikation krebsartiger krankheiten
EP1994146A4 (de) Krebserkrankung-modifizierender antikörper 141205-02
ZA200903282B (en) Cancerous disease modifying antibodies
EP1920066A4 (de) Antikörper, die krebserkrankungen modifizieren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties